|
Volumn 86, Issue 9 I, 1996, Pages 1136-1137
|
Benzydamine hydrochloride (Andolex) improves oral mucosal health in the immunocompromised patient [2]
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZYDAMINE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
HUMAN;
IMMUNE DEFICIENCY;
LETTER;
LEUKEMIA;
MAJOR CLINICAL STUDY;
MOUTH DISEASE;
MOUTH HYGIENE;
ORAL DRUG ADMINISTRATION;
QUALITY OF LIFE;
ANTINEOPLASTIC AGENTS;
BENZYDAMINE;
HEMATOLOGIC DISEASES;
HUMANS;
MOUTH DISEASES;
|
EID: 0029912103
PISSN: 02569574
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (0)
|